FSA
NVO

Financial Security Advisor’s Novo Nordisk NVO Stock Holding History

Financial Security Advisor’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,533
Closed -$219K – 121
2024
Q2 		$219K Buy
+1,533
New +$203K 0.07% 99

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Financial Security Advisor's NVO Position: Q3 2024 in Review

Financial Security Advisor sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 1,533 shares — an estimated $219K sold.

Financial Security Advisor first reported a position in NVO in Q2 2024 and held it in 1 quarter. The position peaked at $219K in Q2 2024. 1,786 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Financial Security Advisor reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • Financial Security Advisor sold 1,533 Novo Nordisk shares in Q3 2024, an estimated $219K.
  • Financial Security Advisor first reported a position in Novo Nordisk in Q2 2024 and held it in 1 quarter.
  • Financial Security Advisor's Novo Nordisk position peaked at $219K in Q2 2024.
  • 1,786 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Financial Security Advisor's 13F filing for Q3 2024, filed 30 Oct 2024.